<DOC>
	<DOC>NCT00067457</DOC>
	<brief_summary>The purpose of this study is to compare the safety and effectiveness of as needed versus fixed dosing of an investigational medication for women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy.</brief_summary>
	<brief_title>Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Alosetron</mesh_term>
	<criteria>Diagnosed with severe diarrheapredominant Irritable Bowel Syndrome (IBS). Failed conventional therapy. Willing to make daily calls on a touchtone telephone. Exclusion criteria: History of or current chronic or severe constipation. Bloody diarrhea, abdominal pain with rectal bleeding. Thrombophlebitis. Abnormal thyroid stimulating hormone (TSH) value. Alcohol and/or substance abuse within past two years. Pregnant or lactating. History/treatment of malignancy within past five years.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>PRN</keyword>
	<keyword>Diarrhea-Predominant Irritable Bowel Syndrome</keyword>
	<keyword>Irritable Bowel Syndrome (IBS)</keyword>
</DOC>